Topic resource collection
Approved comparison material connected to this topic.
117 resourcesRead both sides
How the two research blends compare with standalone GHK-Cu. Formulations can vary between suppliers; the table reflects the blends as offered by Stemcode. BPC-157 + TB-500 + GHK-Cu BPC-157 + TB-500 + GHK-Cu + KPV GHK-Cu (Copper T…
Dose Range Gramicidin 0.025–0.25 mg/mL Daptomycin 4–6 mg/kg Frequency Multiple times daily Once daily Administration Topical application (primary clinical route) Intravenous infusion over 30 minutes (FDA-approved) Cycle Length 8-…
Dose Range Nisin 2.5–25 mg/kg (food preservation; ADI 0.13 mg/kg BW) Daptomycin 4–6 mg/kg Frequency Once daily Administration Oral (food-grade preservative, GRAS) Intravenous infusion over 30 minutes (FDA-approved) Cycle Length O…
Dose Range PACAP-38 5 pmol/kg/min–20 pmol/kg/min mg VIP (Vasoactive Intestinal Peptide) 67 mcg/day–300 mcg/day mcg Frequency Once daily Administration Intravenous infusion Cycle Length Ongoing/indefinite Onset Speed Moderate (1-2…
Dose Range Leuprolide 3.75 mg–45 mg monthly or 3-month injections (depending on formulation) Triptorelin 0.1 mg–22.5 mg mg Frequency Once daily Administration Subcutaneous injection (daily) Intramuscular injection Cycle Length On…
Dose Range Magainin-2 1–5 mg LL-37 0.5–1.6 mg/mL (topical) Frequency Multiple times daily Once daily Administration Topical application (primary clinical route) Topical application (wound healing) Cycle Length 4-6 weeks 12+ weeks…
Dose Range Lactoferricin B 1–10 mg LL-37 0.5–1.6 mg/mL (topical) Frequency Multiple times daily Once daily Administration Oral (research — resistant to gastric digestion) Topical application (wound healing) Cycle Length 4-6 weeks…
Dose Range Polymyxin B 1.5–2.5 mg/kg Daptomycin 4–6 mg/kg Frequency Multiple times daily Once daily Administration Intravenous infusion (primary systemic route) Intravenous infusion over 30 minutes (FDA-approved) Cycle Length 4-6…
Dose Range Buserelin 200 mcg–1,500 mcg mcg Leuprolide 3.75 mg–45 mg monthly or 3-month injections (depending on formulation) Frequency Once daily Administration Subcutaneous injection Subcutaneous injection (daily) Cycle Length O…
Dose Range Defensin (HBD-3) 1–50 μg/mL (research) LL-37 0.5–1.6 mg/mL (topical) Frequency As needed Once daily Administration Topical application (research/wound care) Topical application (wound healing) Cycle Length Ongoing/inde…
Dose Range Cathelicidin (hCAP-18 / Synthetic Derivatives) 0.5–5 mg LL-37 0.5–1.6 mg/mL (topical) Frequency Once daily Administration Topical application (primary research route) Topical application (wound healing) Cycle Length 4-…
Dose Range Enalapril 2.5 mg–40 mg mg Angiotensin (1-7) 0.5-1 mcg/kg–5-10 mcg/kg mcg Frequency Once daily Administration Oral tablet As directed by healthcare provider Cycle Length Ongoing/indefinite Onset Speed Moderate (1-2 week…
Dose Range PNC-27 1–2 mg LL-37 0.5–1.6 mg/mL (topical) Frequency Once daily Administration Subcutaneous injection Topical application (wound healing) Cycle Length 4-6 weeks 12+ weeks Onset Speed Rapid (hours to days) Moderate (1-…
Dose Range VIP (Vasoactive Intestinal Peptide) 67 mcg/day–300 mcg/day mcg PACAP-38 5 pmol/kg/min–20 pmol/kg/min mg Frequency Once daily Administration Intravenous infusion Cycle Length Ongoing/indefinite Onset Speed Moderate (1-2…
Dose Range Triptorelin 0.1 mg–22.5 mg mg Leuprolide 3.75 mg–45 mg monthly or 3-month injections (depending on formulation) Frequency Once daily Administration Intramuscular injection Subcutaneous injection (daily) Cycle Length On…
Research from institutions studying peptide immunomodulation has revealed a persistent misconception: KPV and LL-37 are frequently grouped together in immune system research, yet they operate through fundamentally distinct mechan…
The table below summarises the key distinguishing characteristics between KPV and LL-37 across structure, mechanism, application, and handling. Molecular Weight 341 Da (tripeptide) 4493 Da (37 amino acids) KPV is 13× smaller, ena…